The spatial biology company Lunaphore, a Bio-Techne brand, and SIB have been awarded Innosuisse funding for an innovation project. The collaboration aims to develop novel AI-based tools to assist in assay development for spatial biology on Lunaphore’s proprietary platform COMET™. This will further accelerate spatial biology adoption in any research project, including in the clinic where the technology can speed up the discovery of next-generation therapeutic interventions.
Addressing the needs of life scientists with new technology
Spatial biology utilizes detailed tissue analysis and intracellular interactions to acquire profound insights in cancer biology, immuno-oncology, and other research fields. However, technical hurdles still stand in the way of spatial biology technologies entering clinics and becoming guiding tools for personalized therapies. Lunaphore‘s COMET product suite provides the first universal, end-to-end spatial biology solution to this end. It answers the needs of the scientific community in translational and clinical research. And to further advance the adoption of spatial biology, COMET offers multiplex sequential immunofluorescence imaging (seqIF™ – read the paper): a powerful protein biomarker detection method relying on in-situ imaging, thanks to a microfluidic chip.
